Literature DB >> 23372344

Primarily screening and analyzing ESTs differentially expressed in rats' primary liver cancer.

Dandan Liu1, Lijuan Zhi, Mingxia Ma, Dan Qiao, Meijuan Wang, Yawei Wang, Baijie Jin, Anqi Li, Guting Liu, Yiqing Zhang, Yanyan Song, Hongxu Zhang.   

Abstract

OBJECTIVE: To screen and analyze key express sequence tags (ESTs) which were differentially displayed in every period of SD rats' primary hepatic carcinoma and reveal the molecular mechanism of carcinogenesis.
METHODS: Using diethylnitrosamine (DENA) as a cancerigenic agent, animal models with different phases of primary hepatic cancer were constructed in SD rats. Rats were respectively sacrificed at d 14, d 28, d 56, d 77, d 105 and d 112 after the rats received DENA by gavage, then the livers were harvested. One part of the livers was classified according to their pathological changes, while the other was reserved for molecular mechanism studies on hepatocarcinogenesis. The differentially expressed genes were isolated from both normal and morbid tissues by mRNA differential display technique (DDRT-PCR). After the fragments were sequenced, bioinformatics were used to analyze the results.
RESULTS: Twelve differentially expressed cDNA fragments were obtained. Nine fragments had the homology with known cDNA clones, especially EST-7 was similar to BN/SsNHsdMCW mitochondrion gene and the identity was 100% which suggested EST-7 may be the part of BN/SsNHsdMCW mitochondrion gene. In contrast, other three fragments (EST-1, EST-3 and EST-5) had extremely low identity to any genes registered in GENBANK databases.
CONCLUSIONS: BN/SsNHsdMCW mitochondrion gene was expressed in different periods of hepatocarcinogenesis. Moreover, EST-1, EST-3 and EST-5 were suggested to contribute to the development of rat hepatocarcinogenesis, and thus may be candidates of new targets of oncogenes or cancer suppressor genes.

Entities:  

Keywords:  Animal models of primary liver cancer; DDRT-PCR (differential display reverse transcription PCR); ESTs (express sequence tags); mitochondrion gene

Year:  2013        PMID: 23372344      PMCID: PMC3555298          DOI: 10.3978/j.issn.1000-9604.2012.12.03

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  33 in total

1.  Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains.

Authors:  Michal Pravenec; Masaya Hyakukoku; Josef Houstek; Vaclav Zidek; Vladimir Landa; Petr Mlejnek; Ivan Miksik; Kristyna Dudová-Mothejzikova; Petr Pecina; Marek Vrbacky; Zdenek Drahota; Alena Vojtiskova; Tomas Mracek; Ludmila Kazdova; Olena Oliyarnyk; Jiaming Wang; Christopher Ho; Nathan Qi; Ken Sugimoto; Theodore Kurtz
Journal:  Genome Res       Date:  2007-08-10       Impact factor: 9.043

2.  Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.

Authors:  Xiaoling Xu; Shogo Kobayashi; Wenhui Qiao; Cuiling Li; Cuiying Xiao; Svetlana Radaeva; Bangyan Stiles; Rui-Hong Wang; Nobuya Ohara; Tadashi Yoshino; Derek LeRoith; Michael S Torbenson; Gregory J Gores; Hong Wu; Bin Gao; Chu-Xia Deng
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

3.  Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags.

Authors:  Ai-Guo Wang; Sun Young Yoon; Jung-Hwa Oh; Yeo-Jin Jeon; Mirang Kim; Jeong-Min Kim; Sang-Soon Byun; Jin Ok Yang; Joo Heon Kim; Dae-Ghon Kim; Young-Il Yeom; Hyang-Sook Yoo; Yong Sung Kim; Nam-Soon Kim
Journal:  Biochem Biophys Res Commun       Date:  2006-05-11       Impact factor: 3.575

Review 4.  DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors.

Authors:  Sajjad Hussain; Ying Zhang; Paul J Galardy
Journal:  Cell Cycle       Date:  2009-06-01       Impact factor: 4.534

5.  A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines.

Authors:  Piotr Jasinski; Brandon Welsh; Jorge Galvez; David Land; Pawel Zwolak; Lori Ghandi; Kaoru Terai; Arkadiusz Z Dudek
Journal:  Invest New Drugs       Date:  2007-10-24       Impact factor: 3.850

6.  The mutation of the LEW.1AR1-iddm rat maps to the telomeric end of rat chromosome 1.

Authors:  Heike Weiss; Tanja Arndt; Anne Jörns; Sigurd Lenzen; Edwin Cuppen; Hans J Hedrich; Markus Tiedge; Dirk Wedekind
Journal:  Mamm Genome       Date:  2008-03-21       Impact factor: 2.957

7.  Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Authors:  Feng Jiang; Qi Qiu; Abha Khanna; Nevins W Todd; Janaki Deepak; Lingxiao Xing; Huijun Wang; Zhenqiu Liu; Yun Su; Sanford A Stass; Ruth L Katz
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

Review 8.  Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.

Authors:  Shu-Chun Chuang; Carlo La Vecchia; Paolo Boffetta
Journal:  Cancer Lett       Date:  2008-12-16       Impact factor: 8.679

Review 9.  Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis.

Authors:  Jianxin Lu; Lokendra Kumar Sharma; Yidong Bai
Journal:  Cell Res       Date:  2009-07       Impact factor: 25.617

Review 10.  Cholangiolocellular carcinoma containing hepatocellular carcinoma and cholangiocellular carcinoma, extremely rare tumor of the liver:a case report.

Authors:  Mami Kanamoto; Tomoharu Yoshizumi; Toru Ikegami; Satoru Imura; Yuji Morine; Tetsuya Ikemoto; Nobuya Sano; Mitsuo Shimada
Journal:  J Med Invest       Date:  2008-02
View more
  2 in total

Review 1.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

2.  Phytofabrication of Silver nanoparticles: Novel Drug to overcome hepatocellular ailments.

Authors:  Asha Singh; Mohd Yaqoob Dar; Beenu Joshi; Bhawna Sharma; Sadhana Shrivastava; Sangeeta Shukla
Journal:  Toxicol Rep       Date:  2018-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.